CCM
CVAC

Camber Capital Management’s CureVac CVAC Stock Holding History

Camber Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-550,000
Closed -$1.87M – 37
2024
Q2 		$1.87M Sell
550,000
-1,200,000
-69% -$3.92M 0.05% 36
2024
Q1 		$5.3M Hold
1,750,000
– – 0.13% 35
2023
Q4 		$7.37M Hold
1,750,000
– – 0.19% 38
2023
Q3 		$12M Buy
1,750,000
+287,500
+20% +$2.54M 0.39% 34
2023
Q2 		$15.2M Buy
1,462,500
+212,500
+17% +$1.9M 0.5% 31
2023
Q1 		$8.71M Buy
+1,250,000
New +$10.9M 0.27% 37

Other funds holding CVAC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Camber Capital Management's CVAC Position: Q3 2024 in Review

Camber Capital Management sold out of CureVac (CVAC) in Q3 2024, closing a stake of 550,000 shares — an estimated $1.87M sold.

Camber Capital Management first reported a position in CVAC in Q1 2023 and held it in 6 quarters. The position peaked at $15.2M in Q2 2023. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

  • Camber Capital Management reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
  • Camber Capital Management sold 550,000 CureVac shares in Q3 2024, an estimated $1.87M.
  • Camber Capital Management first reported a position in CureVac in Q1 2023 and held it in 6 quarters.
  • Camber Capital Management's CureVac position peaked at $15.2M in Q2 2023.
  • 81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Camber Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.